Visit "Where can I get vaccinated" or call 1-877-COVAXCO (1-877-268-2926) for vaccine information.

Colorado Podiatry Board
0
  1. Home
  2. DPO Home
  3. Podiatry HOME

Podiatry HOME

Welcome to the Podiatry Homepage

The Colorado Podiatry Board was instituted as part of the Podiatrists Practice Act in order to regulate the practice of podiatry in Colorado. The Board ensures that licensed professionals are acting in accordance with the standards of care as outlined in the Podiatrists Practice Act. Licensure is mandatory to practice podiatric medicine or perform podiatric surgery in Colorado or to treat Colorado patients.

The Podiatry Board is a Type I Board, meaning that it is policy autonomous and made up of professional and public members (four podiatrists and one public member). The decisions made by the Podiatry Board are not subject to administrative review. The Podiatry Board does not have the authority to arbitrate or adjudicate fee disputes.

Program Information

Program/Board Members

Karen Phelan, Program Director

Colorado Podiatry Board
1560 Broadway, Suite 1350
Denver, CO 80202

Phone: 303-894-7800  |  Fax: 303-894-7764  |  Email: dora_podiatryboard@state.co.us

 

Board Members:

  • Kristine Hoffman, DPM, President
    Professional Member | Term Expires: March 17, 2023

  • Brett D. Sachs, DPM, Vice President
    Professional Member | Term Expires: March 17, 2025

  • Michael Vaardahl, DPM
    Professional Member | Term Expires: March 17, 2024

  • Staci Bogin, DPM
    Professional Member | Term Expires: March 17, 2024

  • Ora DeMorrow
    Public Member | Term Expires: March 17, 2026

Public Notices

Permanent Rulemaking Hearing - June 3, 2022

The Colorado Podiatry Board will hold a Permanent Rulemaking Hearing to allow stakeholders a final opportunity to provide testimony before the Board considers adopting the proposed changes throughout the Board’s rules pursuant to the rule review mandated by section 24-4-103.3, C.R.S. The purpose of the rule review is to assess the continuing need, appropriateness, and cost-effectiveness of the rules to determine if they should be continued in their current form, modified, or repealed. Some of the major proposed changes include the consolidation of all Board rules into one document, and a complete re-organization of the rules. 

 

Stakeholder Meeting - April 8, 2022

The Colorado Podiatry Board will hold a Second Stakeholder Meeting to allow stakeholders another opportunity to provide feedback on the proposed changes to the Board’s rules pursuant to the rule review mandated by section 24-4-103.3, C.R.S. The purpose of the rule review is to assess the continuing need, appropriateness, and cost-effectiveness of the rules to determine if they should be continued in their current form, modified, or repealed. The Board is also requesting stakeholder input on any additional rule revisions that should be considered. 

 

Joint Stakeholder Meeting - October 15, 2021

The State Board of Pharmacy, State Board of Nursing, Colorado Medical Board, Colorado Dental Board, Colorado Podiatry Board, State Board of Veterinary Medicine, and State Board of Optometry held a Joint Stakeholder Meeting to gather feedback to identify and create a list of prescription drugs and substances (using evidence-based practices), in addition to controlled substances, that have a substantial potential for abuse and must require pharmacists and prescription drug outlets to report those prescription drugs and substances to the Prescription Drug Monitoring Program (PDMP) when dispensed to a patient. The Board is considering the development of new rules to monitor non-controlled prescription drugs/substances, as allowed per section 12-280-404(2)(b)(I), C.R.S., of Colorado Senate Bill 21-098.

 

Permanent Rulemaking Hearing - September 10, 2021

The Colorado Podiatry Board held a Permanent Rulemaking Hearing on September 10, 2021, that allow stakeholders a final opportunity to provide feedback before the Board considered adopting Rule 330 (3 CCR 712-21), to implement Colorado House Bill 21-1276 (Concerning the prevention of substance use disorders).

 

Permanent Rulemaking Hearing - June 4, 2021

The Colorado Podiatry Board held a Permanent Rulemaking Hearing on June 4, 2021, that allowed stakeholders a final opportunity to provide feedback before the Board considered adopting revisions to Rule 310, to correct language in the rule that conflicted with portions of the statute in section 12-30-115, C.R.S., of Colorado Senate Bill 20-102 (Concerning required disclosures to patients regarding formal actions based on sexual misconduct).

 

Permanent Rulemaking Hearing - December 4, 2020

The Colorado Podiatry Board held a virtual Permanent Rulemaking Hearing to consider adopting new rules to implement Colorado Senate Bill 19-079 (Requirement of Practitioners to Prescribe Controlled Substances Electronically), and Colorado Senate Bill 20-102 (Concerning the Requirement of Providers to provide Disclosure of Sexual Misconduct to Patients prior to Treatment).

Legislative Updates
Meeting Minutes
Open Embed